Kalluri Aravind G, Jain Ashish K, Rodriguez Heron E, Eskandari Mark K
Division of Vascular Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL.
Division of Vascular Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL.
Ann Vasc Surg. 2019 Jul;58:289-294. doi: 10.1016/j.avsg.2018.12.068. Epub 2019 Feb 13.
Primary leiomyosarcoma of the inferior vena cava (IVC) is a rare soft tissue sarcoma. Techniques for caval reconstruction after tumor resection vary widely. Our single-center experience serves as one of the largest reviews of caval reconstruction using polytetrafluoroethylene (PTFE) interposition grafts published in the past 10 years.
We conducted a single-center retrospective review of all patients who had undergone surgical resection of IVC leiomyosarcomas since January 1, 2007. Information regarding the procedure and patient-specific data was obtained from the institution's electronic medical record.
We identified 4 patients (3 women and 1 man) who had undergone surgical resection for IVC leiomyosarcoma with PTFE graft reconstruction. Adjunct procedures (i.e., arteriovenous fistulas) were not used to maintain graft patency. There was no perioperative mortality within our patient population. One patient returned within 30 days with an acute kidney injury associated with a partially occlusive thrombus in the proximal part of the PTFE conduit. Another patient was found to have infolding of the PTFE graft due to inappropriate graft oversizing at the time of the index operation. Two patients developed distant metastases within a year of surgery, despite having tumor-free margins at the time of the initial operation. All the PTFE interposition grafts remained patent throughout the follow-up without the need for an additional intervention.
PTFE interposition graft may be a safe and effective conduit for caval reconstruction after resection of a primary leiomyosarcoma of the IVC, but further research is necessary to establish appropriate management guidelines.
原发性下腔静脉平滑肌肉瘤是一种罕见的软组织肉瘤。肿瘤切除后下腔静脉重建技术差异很大。我们单中心的经验是过去10年发表的关于使用聚四氟乙烯(PTFE)置入移植物进行下腔静脉重建的最大规模综述之一。
我们对2007年1月1日以来所有接受下腔静脉平滑肌肉瘤手术切除的患者进行了单中心回顾性研究。有关手术过程和患者特定数据的信息从该机构的电子病历中获取。
我们确定了4例患者(3名女性和1名男性)接受了下腔静脉平滑肌肉瘤手术切除并使用PTFE移植物重建。未使用辅助程序(即动静脉瘘)来维持移植物通畅。我们的患者群体中没有围手术期死亡病例。1例患者在30天内因PTFE导管近端部分出现部分闭塞性血栓而出现急性肾损伤。另1例患者在初次手术时因移植物尺寸选择不当发现PTFE移植物内折。2例患者在手术后一年内发生远处转移,尽管初次手术时切缘无肿瘤。所有PTFE置入移植物在随访期间均保持通畅,无需额外干预。
PTFE置入移植物可能是下腔静脉原发性平滑肌肉瘤切除后下腔静脉重建的一种安全有效的管道,但需要进一步研究以建立适当的管理指南。